RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Smyrna, GA · +42 more sites
3 recruiting multiple sclerosis studies with a site in Smyrna, GA.
Sponsor: Novartis Pharmaceuticals
Smyrna, GA · +42 more sites
Sponsor: Sanofi
Atlanta, GA · Smyrna, GA · +32 more sites
Sponsor: TG Therapeutics, Inc.
Atlanta, GA · Savannah, GA · +106 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.